Nav: Home

Study: Privacy concerns keep men from HIV testing, treatment

March 25, 2019

Privacy concerns linked to both health facilities and providers are major barriers to increasing the number of men who are tested and treated for HIV in Cote d'Ivoire, suggests new Johns Hopkins Center for Communication Programs (CCP) research. CCP is based at the Johns Hopkins Bloomberg School of Public Health.

The findings, published March 21 in the journal PLOS ONE, are based on interviews with 277 men who were either living with HIV or didn't know their HIV status.

Men across sub-Saharan Africa are less likely to be tested for HIV or treated after being diagnosed. For example, in Cote d'Ivoire, 60 percent of women ages 15 and older who are living with HIV are on antiretroviral therapy (ART) as compared to 29 percent of their male counterparts, according to UNAIDS.

"It's not that going to the health facility doesn't occur to men," says CCP's Natalie Jean Tibbels, MSPH, the study's lead author. "But when it comes to HIV, there is a sense that while you might get good treatment, there might be ramifications resulting from going to the clinic. Men in the study were willing to forfeit the benefits of testing and treatment because the costs of being known as HIV positive or stigmatized were too high."

Men interviewed for the study reported both costs and benefits related to interactions with health providers. Costs included the fear of unwanted disclosure, actual or anticipated stigmatization and the belief that providers were not administering the HIV test properly. These downsides were offset by the perceived benefit of social support from the provider and clinical guidance on the treatment journey.

Men in the study also identified concerns linked to the health facility itself. They worried that the layout of the clinic - where clients with HIV waited or which providers they saw - might reveal their HIV status. Even just being in the clinic could be enough to make people in their communities believe that they are living with HIV. Men also identified long wait times and days when ART was out of stock as well as other costs. Some men also said that health clinics were for women and children, not men.

Tibbels says that men in the study who did seek care in the facility tended to report afterwards that they were well treated and that many of their fears weren't realized. One man with HIV who received treatment at the facility said: "[The providers] truly motivated me a lot, [and] gave me hope that one day I can witness the wonders of treatment."

However, for many men in the study, particularly those whose HIV status was unknown, the drawbacks associated with seeking care at the health facility were difficult to overcome. One man with HIV told researchers that his experience in the health facility led him to seek guidance from the internet and care from traditional healers instead of in-person treatment.

"I condemn above all the behavior of certain health providers. Their reception is disappointing," he said. "When they discover it is HIV, they give you a weird look. When your back is turned, the staff laughs. I lived it yesterday and it hurt me."

These results suggest that along with taking men's concerns and preferences into account in the design of facilities and in provider training sessions, interventions that allow for men to be tested and treated outside of the health facility should also be encouraged.

"If men have hesitations around getting HIV services at a formal health facility, then we need to think outside the box," Tibbels says. "We need to take their concerns to heart in order to be successful in getting more men into treatment. If that means making it possible for men to be tested and treated outside of the health facility, it's something we should do."

CCP's Brothers for Life program, for example, creates space for men to talk about many life concerns, including HIV, and testing is provided in the community. The program offers a place where men can get social support and also links them, should they be diagnosed with HIV, with peer navigators who help them to quickly get the treatment and encouragement they need.

"Understanding the perspective of men is critical to tailoring health communication and clinical services to meet their needs," Tibbels says.
-end-
The research was funded through USAID with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) as part of the CCP-led Health Communication Capacity Collaborative project and has further informed the Breakthrough ACTION project.

"Men's perceptions of HIV care engagement at the facility- and provider-levels: experiences in Cote d'Ivoire" was written by Natalie Jean Tibbels, Zoé Mistrale Hendrickson, Danielle Amani Naugle, Abdul Dosso, Lynn M. Van Lith, Elizabeth C. Mallalieu, Anne Marie Kouadio, Walter Kra, Diarra Kamara, Patricia Dailly-Ajavon, Adama Cisse, Kim Seifert-Ahanda, Sereen Thaddeus, Stella Babalola and Christopher J. Hoffmann.

Johns Hopkins University Bloomberg School of Public Health

Related Hiv Articles:

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.
Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.
The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
First ever living donor HIV-to-HIV kidney transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
More HIV News and HIV Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.